EDWARDS LIFESCIENCES CORPORATION Edwards Lifesciences Corporation Share Price BOERSE MUENCHEN
Equities
EWL
US28176E1082
Advanced Medical Equipment & Technology
|
Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
| 79.01 EUR | -0.42% |
|
-1.65% | +13.51% |
| 05-01 | Edwards Lifesciences Insider Sold Shares Worth $1,212,687, According to a Recent SEC Filing | MT |
| 04-30 | Edwards Lifesciences Insider Sold Shares Worth $622,062, According to a Recent SEC Filing | MT |
| Sales 2024 * | 6.56B 6.09B 522B | Sales 2025 * | 7.2B 6.69B 573B | Capitalization | 51.37B 47.71B 4,090B |
|---|---|---|---|---|---|
| Net income 2024 * | 1.62B 1.51B 129B | Net income 2025 * | 1.86B 1.73B 148B | EV / Sales 2024 * | 7.57 x |
| Net cash position 2024 * | 1.68B 1.56B 134B | Net cash position 2025 * | 2.84B 2.64B 226B | EV / Sales 2025 * | 6.74 x |
| P/E ratio 2024 * |
32.1
x | P/E ratio 2025 * |
27.7
x | Employees | - |
| Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 91.6% |
More Fundamentals
* Assessed data
More news
Latest transcript on Edwards Lifesciences Corporation
More recommendations
More press releases
More news
| 1 week | -1.65% | ||
| Current month | -0.13% | ||
| 1 month | -7.58% | ||
| 3 months | -0.30% | ||
| 6 months | +26.46% | ||
| Current year | +13.51% |
1 week
78.23
81.22
1 month
78.2386.53
3 years
57.08119.48
| Managers | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 56 | 31/12/14 | |
| Chairman | 71 | 31/12/99 | |
Scott Ullem
DFI | Director of Finance/CFO | 57 | 31/12/13 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Leslie Heisz
BRD | Director/Board Member | 63 | 04/07/16 |
| Director/Board Member | 67 | 12/11/14 | |
Steven Loranger
BRD | Director/Board Member | 72 | 15/03/16 |
| Date | Price | Change | Volume |
|---|---|---|---|
| 06/05/24 | 79.01 | -0.42% | 139 |
| 03/05/24 | 79.34 | +0.21% | 49 |
| 02/05/24 | 79.17 | -0.34% | 156 |
| 30/04/24 | 79.44 | -0.63% | 65 |
| 29/04/24 | 79.94 | -0.90% | 75 |
Real-time BOERSE MUENCHEN, May 06, 2024 at 08:44 pm
More quotes
Edwards Lifesciences Corporation specializes in designing, manufacturing and marketing medical systems and devices for treating cardiovascular diseases. Net sales break down by family of products as follows:
- heart valves and surgery products (67.9%);
- hemodynamic monitoring systems (15.5%);
- other (16.6%): balloon catheters, artificial implants, etc.
Net sales are distributed geographically as follows: the United States (58.4%), Europe (22.2%), Japan (7.6%) and other (11.8%).
Calendar
07/05/2024
- Annual General Meeting
Related indices
Trading Rating
Investor Rating
ESG Refinitiv
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
31
Last Close Price
85.25
USD
Average target price
95.24
USD
Spread / Average Target
+11.72%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +8.01% | 218B | |
| +6.91% | 184B | |
| +13.33% | 135B | |
| -0.27% | 62.38B | |
| +7.76% | 50.9B | |
| +1.27% | 40.87B | |
| +2.99% | 36.28B | |
| +26.03% | 31.88B | |
| +17.81% | 24.39B |
- Stock Market
- Equities
- EW Stock
- EWL Stock
